Inhibiting the inhibitors at the cellular level.
作者信息
Scott David W
机构信息
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
出版信息
Mol Ther. 2024 Oct 2;32(10):3203. doi: 10.1016/j.ymthe.2024.09.003. Epub 2024 Sep 15.
Abstract
摘要
相似文献
1
Inhibiting the inhibitors at the cellular level.在细胞水平上抑制抑制剂。
Mol Ther. 2024 Oct 2;32(10):3203. doi: 10.1016/j.ymthe.2024.09.003. Epub 2024 Sep 15.
2
Anterior Cervical Discectomy and Fusions Supplemented With Cellular or Noncellular Allografts Have Similar Radiographic Fusion and Clinical Outcomes.前路颈椎间盘切除融合术联合细胞或非细胞同种异体移植物的影像学融合和临床结果相似。
Clin Spine Surg. 2023 Dec 1;36(10):426-430. doi: 10.1097/BSD.0000000000001475. Epub 2023 Jun 20.
3
A Systematic Review of PCSK9 Inhibitors Alirocumab and Evolocumab.PCSK9 抑制剂依洛尤单抗和阿利西尤单抗的系统评价
J Manag Care Spec Pharm. 2016 Jun;22(6):641-653q. doi: 10.18553/jmcp.2016.22.6.641.
4
Physostigmine for Alzheimer's disease.用于治疗阿尔茨海默病的毒扁豆碱。
Cochrane Database Syst Rev. 2001;2001(2):CD001499. doi: 10.1002/14651858.CD001499.
5
Secondary Prevention Medications in 17 Countries Grouped by Income Level (PURE): A Prospective Cohort Study.按收入水平分组的17个国家的二级预防药物（PURE）：一项前瞻性队列研究。
J Am Coll Cardiol. 2025 Feb 11;85(5):436-447. doi: 10.1016/j.jacc.2024.10.121.
6
Safety and efficacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease.质子泵抑制剂在患有胃食管反流病的早产儿中的安全性和有效性。
Cochrane Database Syst Rev. 2025 Mar 11;3(3):CD015127. doi: 10.1002/14651858.CD015127.pub2.
7
PPARγ inhibitors enhance the efficacy of statin therapy for steroid-induced osteonecrosis of the femoral head by directly inhibiting apoptosis and indirectly modulating lipoprotein subfractions.过氧化物酶体增殖物激活受体γ（PPARγ）抑制剂通过直接抑制细胞凋亡和间接调节脂蛋白亚组分，增强他汀类药物治疗激素性股骨头坏死的疗效。
PLoS One. 2025 Jun 20;20(6):e0325190. doi: 10.1371/journal.pone.0325190. eCollection 2025.
8
Factors associated with the use of sodium-glucose cotransporter 2 (SGLT2) inhibitors after an episode of acute heart failure and prognostic impact.急性心力衰竭发作后使用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的相关因素及预后影响。
Rev Clin Esp (Barc). 2025 Jun-Jul;225(6):502300. doi: 10.1016/j.rceng.2025.502300. Epub 2025 Apr 30.
9
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer.聚（ADP-核糖）聚合酶（PARP）抑制剂治疗卵巢癌。
Cochrane Database Syst Rev. 2022 Feb 16;2(2):CD007929. doi: 10.1002/14651858.CD007929.pub4.
10
Rivastigmine for Alzheimer's disease.用于治疗阿尔茨海默病的卡巴拉汀
Cochrane Database Syst Rev. 2000(2):CD001191. doi: 10.1002/14651858.CD001191.
本文引用的文献
1
Blunting specific T-dependent antibody responses with engineered "decoy" B cells.利用工程化“诱饵”B 细胞来钝化特定的 T 依赖性抗体反应。
Mol Ther. 2024 Oct 2;32(10):3453-3469. doi: 10.1016/j.ymthe.2024.08.023. Epub 2024 Aug 26.
Zotero 插件